Current portfolio

Xilis

Micro-organoid technology for precision cancer therapy and improved drug discovery

  • Sector
    Healthcare
  • Country
    United States
  • Fund
    LSP 6
  • Entry
    2021
  • Web
Xilis
0
EQT logo